Activest Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Activest Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$247	–	1480
2026 Q1	$247	Hold	1,000	–	–	﹤0.01%	1116
2025 Q4	$420	Hold	1,000	–	–	﹤0.01%	1010
2025 Q3	$673	Hold	1,000	–	–	﹤0.01%	932
2025 Q2	$541	Hold	1,000	–	–	﹤0.01%	856
2025 Q1	$656	Hold	1,000	–	–	﹤0.01%	822
2024 Q4	$1.02K	Hold	1,000	–	–	﹤0.01%	462
2024 Q3	$866	Hold	1,000	–	–	﹤0.01%	466
2024 Q2	$358	Buy	+1,000	New	+$540	﹤0.01%	474

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Activest Wealth Management's SGMO Position: Q2 2026 in Review

Activest Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 1,000 shares — an estimated $247 sold.

Activest Wealth Management first reported a position in SGMO in Q2 2024 and held it in 8 quarters. The position peaked at $1.02K in Q4 2024. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Activest Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Activest Wealth Management sold 1,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $247.
Activest Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and held it in 8 quarters.
Activest Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $1.02K in Q4 2024.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.